|
市場調査レポート
商品コード
1566216
イムノヘマトロジーの市場規模、シェア、成長分析、製品別、最終用途別、地域別 - 産業予測、2024年～2031年Immunohematology Market Size, Share, Growth Analysis, By Product (Immunohematology analyzer, Immunohematology reagent), By End Use (Hospitals, Blood banks), By Region - Industry Forecast 2024-2031 |
||||||
|
|||||||
| イムノヘマトロジーの市場規模、シェア、成長分析、製品別、最終用途別、地域別 - 産業予測、2024年～2031年 |
|
出版日: 2024年10月01日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
イムノヘマトロジーの世界市場規模は、2022年に18億3,000万米ドルと評価され、2023年の19億2,000万米ドルから2031年には27億6,000万米ドルに成長し、予測期間（2024-2031年）のCAGRは4.63％で成長する見通しです。
世界のイムノヘマトロジー市場は、輸血需要の高まりと適合血液製剤の必要性によって大きな成長を遂げています。この成長の主な要因としては、輸血医学の進歩、輸血サポートが必要な慢性疾患の有病率の増加、外傷や外科手術の頻度の増加などが挙げられます。革新的技術と自動化ソリューションは、血液型検査と適合性試験の効率と精度を高めています。さらに、分子解析技術への移行により、精度と信頼性が向上しています。しかし、高度な機器や試薬の高コスト、熟練した専門家の不足、厳しい規制要件などの課題が、進展の妨げになる可能性があります。全体として、安全で適合性の高い血液製剤の需要はヘルスケアにおいて引き続き重要であるため、市場は継続的な成長に向けて好位置にあります。
目次
イントロダクション
- 調査の目的
- 定義
- 市場範囲
調査手法
- 情報調達
- 二次データソースと一次データソース
- 市場規模予測
- 市場の想定と制限
エグゼクティブサマリー
- 市場概要見通し
- 供給需要動向分析
- セグメント別機会分析
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- ポーターの分析
主な市場の考察
- 主な成功要因
- 競合の程度
- 主な投資機会
- 市場のエコシステム
- 技術分析
- 規制情勢
- 特許分析
- PESTEL分析
- ケーススタディ分析
イムノヘマトロジー市場：製品別
- 市場概要
- イムノヘマトロジー分析装置
- イムノヘマトロジー試薬
イムノヘマトロジー市場：最終用途別
- 市場概要
- 病院
- 血液銀行
- 診断検査室
イムノヘマトロジー市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
- アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
- ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
- 中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2023年）
- 主な市場企業が採用した戦略
- 市場における最近の活動
- 主要企業の市場シェア（2023年）
主要企業プロファイル
- Grifols
- QuidelOrtho
- Immucor
- Bio-Rad Laboratories
- Beckman Coulter
- Novartis
- Quotient Limited
- Diagast
- Becton, Dickinson and Company
- Thermo Fisher Scientific
- Abbott Laboratories
- BioMerieux
- Hologic, Inc.
- Werfen S.A.
- Merck KGaA
- DiaSorin S.p.A.
- F. Hoffmann-La Roche AG
- Immucor Gamma Biologics
- Tulip Diagnostics Pvt. Ltd.
- Versiti
Global Immunohematology Market size was valued at USD 1.83 billion in 2022 and is poised to grow from USD 1.92 billion in 2023 to USD 2.76 billion by 2031, growing at a CAGR of 4.63% during the forecast period (2024-2031).
The global immunohematology market is experiencing significant growth, driven by the rising demand for blood transfusions and the need for compatible blood products. Key factors contributing to this growth include advancements in transfusion medicine, an increasing prevalence of chronic diseases that necessitate transfusion support, and a higher frequency of trauma and surgical procedures. Innovative technologies and automation solutions are enhancing the efficiency and accuracy of blood typing and compatibility testing. Additionally, the shift toward molecular immunohematology techniques is improving precision and reliability. However, challenges such as the high costs of advanced equipment and reagents, a shortage of skilled professionals, and stringent regulatory requirements may hinder progress. Overall, the market is well-positioned for continued growth, as the demand for safe and compatible blood products remains critical in healthcare settings.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Immunohematology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Immunohematology Market Segmental Analysis
Global Immunohematology Market is segmented by Product, End Use, and region. Based on Product , the market is segmented into Immunohematology analyzer, Immunohematology reagent. Based on End Use, the market is segmented into Hospitals, Blood banks, Diagnostic laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Drivers of the Global Immunohematology Market
One key driver of the global immunohematology market is the escalating demand for blood transfusion services. As the prevalence of chronic diseases, surgical interventions, and trauma cases rises, the need for safe and compatible blood products for transfusions becomes increasingly critical. Immunohematology is essential for ensuring that blood products match the recipient's blood type, thereby minimizing the risk of adverse reactions and enhancing patient outcomes. This necessity fuels the adoption of immunohematology testing and associated products in healthcare facilities.
Restraints in the Global Immunohematology Market
A significant constraint in the global immunohematology market is the high cost associated with testing and equipment. The advanced technologies and specialized reagents required for immunohematology testing can be quite expensive, posing challenges for healthcare facilities, especially in developing regions, to acquire these resources. Additionally, the necessity for skilled personnel to conduct and interpret immunohematology tests further contributes to the overall expenses. These financial limitations can restrict the accessibility and affordability of immunohematology services, particularly in resource-limited settings, ultimately hindering market growth and adoption.
Market Trends of the Global Immunohematology Market
A significant trend in the global immunohematology market is the growing adoption of automated and integrated systems for blood typing and cross-matching. Technological advancements have spurred demand for efficient and precise immunohematology testing methods. These automated systems provide advantages such as minimized human error, enhanced workflow efficiency, and quicker turnaround times for test results. They consolidate various processes, including sample preparation, antibody identification, and data analysis, into a unified platform, thereby boosting laboratory productivity. Additionally, integrating immunohematology systems with laboratory information management systems (LIMS) facilitates seamless data management and better traceability. This move towards automation and integration is motivated by the need for improved patient safety, increased operational efficiency, and enhanced laboratory performance.
Table of Contents
Introduction
- Objectives of the Study
- Definitions
- Market Scope
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Market Overview Outlook
- Supply Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factor
- Degree of Competition
- Top Investment Pockets
- Ecosystem of the Market
- Technology Analysis
- Regulatory Landscape
- Patent Analysis
- PESTEL Analysis
- Case Study Analysis
Immunohematology Market, By Product
- Market Overview
- Immunohematology analyzer
- Immunohematology reagent
Immunohematology Market, By End Use
- Market Overview
- Hospitals
- Blood banks
- Diagnostic laboratories
Immunohematology Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2023
- Strategies Adopted by Key Market Players
- Recent Activities in the Market
- Key Companies Market Share (%), 2023
Key Company Profiles
- Grifols
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- QuidelOrtho
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Immucor
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Beckman Coulter
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novartis
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Quotient Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Diagast
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Becton, Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioMerieux
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hologic, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Werfen S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- DiaSorin S.p.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- F. Hoffmann-La Roche AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Immucor Gamma Biologics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Tulip Diagnostics Pvt. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Versiti
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
